Prenetics Global (PRE) Short term Debt (2022 - 2023)
Prenetics Global's (PRE) quarterly Short term Debt came in at $4.2 million in Q4 2023, little changed year-over-year from $4.2 million in Q4 2022, and little changed quarter-over-quarter from $4.2 million in Q4 2022.
Analysis
Prenetics Global (PRE) Short term Debt (2022 - 2023) Analysis & Trends
Prenetics Global (PRE) has reported Short term Debt for 2 consecutive years, with $4.2 million the latest figure, recorded in Q4 2023.
- On a quarterly basis, Short term Debt changed 0.15% year-over-year to $4.2 million in Q4 2023; TTM through Dec 2023 was $4.2 million, a 0.15% change from a year earlier, with the FY2023 full-year figure at $4.2 million, changed 0.15% from the prior year.
- Short term Debt was $4.2 million for Q4 2023 at Prenetics Global, roughly flat from $4.2 million in the prior quarter.
- Over five years, Short term Debt peaked at $12.1 million in Q1 2022 and troughed at $4.2 million in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - |
| 10 | Prenetics Global | 339.92 Mn | 280.78 Mn | 30.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 4.25 Mn |
| Dec 31, 2022 | 4.24 Mn |
| Jun 30, 2022 | 9.20 Mn |
| Mar 31, 2022 | 12.08 Mn |